BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 29468377)

  • 1. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
    Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test.
    Hilsden RJ; Bridges R; Dube C; McGregor SE; Naugler C; Rose SM; Rostom A; Heitman SJ
    Am J Gastroenterol; 2016 Dec; 111(12):1743-1749. PubMed ID: 27725649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry.
    Anderson JC; Butterly LF; Goodrich M; Robinson CM; Weiss JE
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1308-12. PubMed ID: 23660415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining adenoma detection rate benchmarks in average-risk male veterans.
    El-Halabi MM; Rex DK; Saito A; Eckert GJ; Kahi CJ
    Gastrointest Endosc; 2019 Jan; 89(1):137-143. PubMed ID: 30144416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management.
    Hsu WF; Cheng SY; Shun CT; Chang LC; Tu CH; Wang HP; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1738-1745. PubMed ID: 32187748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial.
    van Doorn SC; van der Vlugt M; Depla A; Wientjes CA; Mallant-Hent RC; Siersema PD; Tytgat K; Tuynman H; Kuiken SD; Houben G; Stokkers P; Moons L; Bossuyt P; Fockens P; Mundt MW; Dekker E
    Gut; 2017 Mar; 66(3):438-445. PubMed ID: 26674360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Surveillance Adenoma and Sessile Serrated Polyp Detection Rates.
    Maratt JK; Dickens J; Schoenfeld PS; Elta GH; Jackson K; Rizk D; Erickson C; Menees SB
    Dig Dis Sci; 2017 Dec; 62(12):3579-3585. PubMed ID: 29043592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
    Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Adenoma and Proximal Sessile Serrated Polyp Detection Rates With Endoscopist Characteristics.
    Sarvepalli S; Garber A; Rothberg MB; Mankaney G; McMichael J; Morris-Stiff G; Vargo JJ; Rizk MK; Burke CA
    JAMA Surg; 2019 Jul; 154(7):627-635. PubMed ID: 30994911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.
    Anderson JC; Butterly LF; Weiss JE; Robinson CM
    Gastrointest Endosc; 2017 Jun; 85(6):1188-1194. PubMed ID: 28153571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
    Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
    Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Hassan C; Senore C; Radaelli F; De Pretis G; Sassatelli R; Arrigoni A; Manes G; Amato A; Anderloni A; Armelao F; Mondardini A; Spada C; Omazzi B; Cavina M; Miori G; Campanale C; Sereni G; Segnan N; Repici A
    Gut; 2017 Nov; 66(11):1949-1955. PubMed ID: 27507903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoma detection rate in high-risk patients differs from that in average-risk patients.
    Sanaka MR; Rai T; Navaneethan U; Gohel TD; Podugu A; Thota PN; Lopez R; Kiran RP; Burke CA
    Gastrointest Endosc; 2016 Jan; 83(1):172-8. PubMed ID: 26024584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopist characteristics that influence the quality of colonoscopy.
    Jover R; Zapater P; Bujanda L; Hernández V; Cubiella J; Pellisé M; Ponce M; Ono A; Lanas A; Seoane A; Marín-Gabriel JC; Chaparro M; Cacho G; Herreros-de-Tejada A; Fernández-Díez S; Peris A; Nicolás-Pérez D; Murcia O; Castells A; Quintero E;
    Endoscopy; 2016 Mar; 48(3):241-7. PubMed ID: 26845473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity.
    Chang LC; Shun CT; Hsu WF; Tu CH; Tsai PY; Lin BR; Liang JT; Wu MS; Chiu HM
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):872-879.e1. PubMed ID: 27498176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.